Difference between revisions of "Top 10 2013-Details About Risk Factors"

From OWASP
Jump to: navigation, search
Line 26: Line 26:
 
     <th>Business Impacts</th>
 
     <th>Business Impacts</th>
 
</tr>
 
</tr>
<tr><td>A1-Injection</td><td>&nbsp;</td>
+
 
 +
<tr><td>[https://www.owasp.org/index.php/A1 A1-Injection]</td><td>&nbsp;</td>
 
{{Top_10_2010:SummaryTableValue-1-Template|Exploitability|EASY|year=2013}}
 
{{Top_10_2010:SummaryTableValue-1-Template|Exploitability|EASY|year=2013}}
 
{{Top_10_2010:SummaryTableValue-2-Template|Prevalence|COMMON|year=2013}}
 
{{Top_10_2010:SummaryTableValue-2-Template|Prevalence|COMMON|year=2013}}
 
{{Top_10_2010:SummaryTableValue-2-Template|Detectability|AVERAGE|year=2013}}
 
{{Top_10_2010:SummaryTableValue-2-Template|Detectability|AVERAGE|year=2013}}
{{Top_10_2010:SummaryTableValue-1-Template|Prevalence|IMPACT|year=2013}}
+
{{Top_10_2010:SummaryTableValue-1-Template|Prevalence|SEVERE|year=2013}}
 +
<td>&nbsp;</td></tr>
  
 +
<tr><td>[https://www.owasp.org/index.php/A2 A2-Injection]</td><td>&nbsp;</td>
 +
{{Top_10_2010:SummaryTableValue-1-Template|Exploitability|EASY|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Prevalence|COMMON|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Detectability|AVERAGE|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-1-Template|Prevalence|SEVERE|year=2013}}
 
<td>&nbsp;</td></tr>
 
<td>&nbsp;</td></tr>
 +
 +
<tr><td>[https://www.owasp.org/index.php/A3 A3-Injection]</td><td>&nbsp;</td>
 +
{{Top_10_2010:SummaryTableValue-1-Template|Exploitability|EASY|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Prevalence|COMMON|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Detectability|AVERAGE|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-1-Template|Prevalence|SEVERE|year=2013}}
 +
<td>&nbsp;</td></tr>
 +
 +
<tr><td>[https://www.owasp.org/index.php/A4 A4-Injection]</td><td>&nbsp;</td>
 +
{{Top_10_2010:SummaryTableValue-1-Template|Exploitability|EASY|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Prevalence|COMMON|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Detectability|AVERAGE|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-1-Template|Prevalence|SEVERE|year=2013}}
 +
<td>&nbsp;</td></tr>
 +
 +
<tr><td>[https://www.owasp.org/index.php/A5 A5-Injection]</td><td>&nbsp;</td>
 +
{{Top_10_2010:SummaryTableValue-1-Template|Exploitability|EASY|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Prevalence|COMMON|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Detectability|AVERAGE|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-1-Template|Prevalence|SEVERE|year=2013}}
 +
<td>&nbsp;</td></tr>
 +
 +
<tr><td>[https://www.owasp.org/index.php/A6 A6]</td><td>&nbsp;</td>
 +
{{Top_10_2010:SummaryTableValue-1-Template|Exploitability|EASY|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Prevalence|COMMON|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Detectability|AVERAGE|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-1-Template|Prevalence|SEVERE|year=2013}}
 +
<td>&nbsp;</td></tr>
 +
 +
<tr><td>[https://www.owasp.org/index.php/A7 A7-Injection]</td><td>&nbsp;</td>
 +
{{Top_10_2010:SummaryTableValue-1-Template|Exploitability|EASY|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Prevalence|COMMON|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Detectability|AVERAGE|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-1-Template|Prevalence|SEVERE|year=2013}}
 +
<td>&nbsp;</td></tr>
 +
 +
<tr><td>[https://www.owasp.org/index.php/A8 A8-Injection]</td><td>&nbsp;</td>
 +
{{Top_10_2010:SummaryTableValue-1-Template|Exploitability|EASY|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Prevalence|COMMON|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Detectability|AVERAGE|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-1-Template|Prevalence|SEVERE|year=2013}}
 +
<td>&nbsp;</td></tr>
 +
 +
<tr><td>[https://www.owasp.org/index.php/A9 A9-Injection]</td><td>&nbsp;</td>
 +
{{Top_10_2010:SummaryTableValue-1-Template|Exploitability|EASY|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Prevalence|COMMON|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Detectability|AVERAGE|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-1-Template|Prevalence|SEVERE|year=2013}}
 +
<td>&nbsp;</td></tr>
 +
 +
<tr><td>[https://www.owasp.org/index.php/A10 A10-Injection]</td><td>&nbsp;</td>
 +
{{Top_10_2010:SummaryTableValue-1-Template|Exploitability|EASY|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Prevalence|COMMON|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-2-Template|Detectability|AVERAGE|year=2013}}
 +
{{Top_10_2010:SummaryTableValue-1-Template|Prevalence|SEVERE|year=2013}}
 +
<td>&nbsp;</td></tr>
 +
 +
 
</table></center> <!-- End risk table -->
 
</table></center> <!-- End risk table -->
  

Revision as of 23:30, 8 March 2013

[[Top 10 {{{year}}}-Note About Risks|← Note About Risks]]
2013 Table of Contents

2013 Top 10 List

 
Top 10 Risk Factor Summary

The following table presents a summary of the 2013 Top 10 Application Security Risks, and the risk factors we have assigned to each risk. These factors were determined based on the available statistics and the experience of the OWASP Top 10 team. To understand these risks for a particular application or organization, you must consider your own specific threat agents and business impacts. Even egregious software weaknesses may not present a serious risk if there are no threat agents in a position to perform the necessary attack or the business impact is negligible for the assets involved.

TABLE GOES HERE


RISK Threat Agents Attack Vectors Security Weakness Technical Impacts Business Impacts
A1-Injection  Exploitability
EASY
Prevalence
COMMON
Detectability
AVERAGE
Prevalence
SEVERE
 
A2-Injection  Exploitability
EASY
Prevalence
COMMON
Detectability
AVERAGE
Prevalence
SEVERE
 
A3-Injection  Exploitability
EASY
Prevalence
COMMON
Detectability
AVERAGE
Prevalence
SEVERE
 
A4-Injection  Exploitability
EASY
Prevalence
COMMON
Detectability
AVERAGE
Prevalence
SEVERE
 
A5-Injection  Exploitability
EASY
Prevalence
COMMON
Detectability
AVERAGE
Prevalence
SEVERE
 
A6  Exploitability
EASY
Prevalence
COMMON
Detectability
AVERAGE
Prevalence
SEVERE
 
A7-Injection  Exploitability
EASY
Prevalence
COMMON
Detectability
AVERAGE
Prevalence
SEVERE
 
A8-Injection  Exploitability
EASY
Prevalence
COMMON
Detectability
AVERAGE
Prevalence
SEVERE
 
A9-Injection  Exploitability
EASY
Prevalence
COMMON
Detectability
AVERAGE
Prevalence
SEVERE
 
A10-Injection  Exploitability
EASY
Prevalence
COMMON
Detectability
AVERAGE
Prevalence
SEVERE
 

TABLE GOES HERE

Additional Risks to Consider

The Top 10 cover a lot of ground, but there are other risks that you should consider and evaluate in your organization. Some of these have appeared in previous versions of the Top 10, and others have not, including new attack techniques that are being identified all the time. Other important application security risks (in alphabetical order) that you should also consider include:


[[Top 10 {{{year}}}-Note About Risks|← Note About Risks]]
2013 Table of Contents

2013 Top 10 List

 

© 2002-2013 OWASP Foundation This document is licensed under the Creative Commons Attribution-ShareAlike 3.0 license. Some rights reserved. CC-by-sa-3 0-88x31.png
[[Category:OWASP Top Ten {{{year}}} Project]]